Public research evidence case
BPC-157 and TB-500 in a Rat Achilles Tendon Model: What the 2026 Study Found
A preclinical evidence case covering the four randomized rat groups, the split biomechanical and histology samples, statistically significant findings and the absence of an added combination benefit.
- Study design
- Randomized four-group exploratory animal study
- Sample
- 32 male Sprague-Dawley rats; 8 per group
- Duration
- 30 postoperative days; outcomes at four weeks
- Model / population
- Rat Achilles tendon transection-and-repair model
Structured evidence record
What the source actually reports
Primary question and endpoints
Maximum load to failure plus Bonar and Movin histology scores, Sirius red collagen organization and collagen I/III immunohistochemistry. Within each group, four tendons were used for biomechanics and four for histology.
Reported result
Maximum load to failure was higher than control for BPC-157 and TB-500 but statistically significant only for TB-500. Total Bonar score was significantly lower with TB-500; total Movin score was significantly lower with TB-500 and the combination. The combination did not confer additional benefit over either agent alone.
Limitations
This was a small exploratory animal study with effective n=4 per group for each analytical stream, one sex, one injury model and one four-week endpoint. It cannot establish human efficacy, clinical dosing, long-term safety or superiority of a blend.
Material and interpretation boundary
The findings are limited to the tested rat model, material, route and protocol. A catalog blend is not validated by the study title alone, and the paper explicitly did not find an added benefit from combining BPC-157 with TB-500.
Why the sample structure matters
The study randomized 32 rats to control, BPC-157, TB-500 or combination groups. Each group contained eight animals, but the tendons were then divided between biomechanical and histological analyses. The effective sample for each analytical stream was therefore four per group. That detail is essential when judging the precision of the results.
Biomechanical and histology outcomes were not identical
Both single-agent groups showed higher maximum load-to-failure values than control, but statistical significance for that endpoint was reported only for TB-500. Histopathology findings varied by scoring system: TB-500 differed from control for total Bonar score, while TB-500 and the combination differed for total Movin score. Collagen analyses added mechanistic context but did not turn the experiment into a human clinical outcome study.
The combination result is easy to misstate
The authors reported that combined BPC-157 and TB-500 did not provide an additional benefit over the individual agents. A page that uses this paper as evidence of “synergy” would reverse the study’s stated finding.
What a stronger evidence chain would require
Replication with larger samples, prospectively defined primary outcomes, longer follow-up and then controlled human research would be needed before clinical conclusions. Separately, any catalog material requires lot-specific identity and quality records; the study cannot authenticate a different batch or formulation.
Primary records
Sources and traceability
- Effects of BPC-157 and TB-500 on Achilles tendon healing in ratsOpen source ↗
Biçer O, et al. Jt Dis Relat Surg. 2026;37:822–837. PMID 42542926.
- Publisher full text and methodsOpen source ↗
Joint Diseases and Related Surgery full-text record, including group allocation and per-analysis sample structure.
This page is an editorial reading of a public source, not a customer testimonial, medical advice or a claim that a catalog material reproduces the cited intervention.